Effect of famotidine on cognitive and behavioral dysfunctions induced in post-COVID-19 infection: A randomized, double-blind, and placebo-controlled study

OBJECTIVES: This is an investigation of the efficacy and safety of famotidine, a selective histamine H2 receptor antagonist, on improvement of cognitive impairment, depression and anxiety symptoms developing post-COVID-19, in a 12-week, randomized controlled trial. METHODS: A total of 50 patients wi...

Descripción completa

Detalles Bibliográficos
Autores principales: Momtazmanesh, Sara, Ansari, Sahar, Izadi, Zahra, Shobeiri, Parnian, Vatankhah, Venus, Seifi, Arash, Ghiasvand, Fereshteh, Bahrami, Mahboobeh, Salehi, Mohammdreza, Noorbala, Ahmad Ali, Akhondzadeh, Shahin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Inc. 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10229204/
https://www.ncbi.nlm.nih.gov/pubmed/37327698
http://dx.doi.org/10.1016/j.jpsychores.2023.111389

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10229204/
https://www.ncbi.nlm.nih.gov/pubmed/37327698
http://dx.doi.org/10.1016/j.jpsychores.2023.111389

Ejemplares similares